BEN YONG (Chief Med & Dev Officer) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/6/2026ACC: 0001193125-26-296502
Officer· Chief Med & Dev Officer
Since Mar 2026
-1.05K
Net shares
Net seller
$8.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.05K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.05K
Price / share
$7.80
Trade value
$8.17K
% of position
2.3%
7/1/2026
45.62K→44.58K
Total
Net shares
−1.05K
Net value
-$8.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | F · Tax Withholding | −1.05K | $7.80 | $8.17K | 2.3% | 45.62K | 44.58K |
| Total | −1.05K | -$8.17K | ||||||
Derivative Transactions0
No derivative transactions reported